Clinical Trial News Archive - September 2022
September 1, 2022
- AlgoTx Announces Initiation of Global Phase 2 Clinical Trial of ATX01 for the Relief of Pain in Chemotherapy-induced Peripheral Neuropathy in Adults
- Positive Results from Full Data Set of its Phase 2 Study of Ifenprodil for IPF and Chronic Cough
September 2, 2022
September 3, 2022
September 4, 2022
September 6, 2022
- Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy
- First Randomized Controlled Study with RejuvenAir for Chronic Bronchitis shows Clinically Significant Results
September 7, 2022
- FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women
- The New England Journal of Medicine Publishes Second Manuscript Reporting Positive Phase 2 Results for Biogen’s Litifilimab (BIIB059) in Lupus
- Clinical Study Commenced for New Potential Treatment for Patients Suffering from Chronic Low Back Pain
September 8, 2022
- Anthos Therapeutics Announces that Abelacimab Has Received FDA Fast Track Designation for the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
- Amgen Announces Positive New Data for Otezla
- Lebrikizumab Dosed Every Four Weeks Maintained Durable Skin Clearance in Lilly's Phase 3 Monotherapy Atopic Dermatitis Trials
- NIH Researchers Develop Gene Therapy for Rare Ciliopathy
- NIH Seeks the Next Generation of COVID-19 Diagnostics
- Clinical Trial Evaluating Monkeypox Vaccine Begins
September 9, 2022
- New Study Suggests Way to Predict Outcomes with High Accuracy Prior to Surgery for Pancreatic Cancer Patients
- U.S. Clinical Trial Evaluating Antiviral for Monkeypox Begins
September 10, 2022
- Novel Regeneron Bispecific Antibodies Show Encouraging Anti-tumor Activity in Two Advanced Solid Tumors
- Bristol Myers Squibb Announces New Sotyktu™ (deucravacitinib) Long-Term Data Showing Clinical Efficacy Maintained for Up to Two Years with Continuous Treatment in Moderate-to-Severe Plaque Psoriasis
- DS-7300 Continues to Show Promising Durable Response in Patients with Several Types of Advanced Cancer
- Novartis Announces Tislelizumab Demonstrated Efficacy and Tolerability in First-Line Advanced Liver Cancer in Phase III Trial
September 11, 2022
September 12, 2022
- Prenatal Cannabis Exposure Associated with Mental Disorders in Children that Persist into Early Adolescence
- Fianlimab (LAG-3 Inhibitor) Combined with Libtayo® (cemiplimab) Demonstrates Greater than 60% Response Rates in Two Independent Cohorts of Patients with Advanced Melanoma Naïve to PD-1 or PD-L1 Inhibitors
- Allakos Announces Initiation of Phase 2b Clinical Trial of Subcutaneous Lirentelimab in Chronic Spontaneous Urticaria (CSU)
- Astellas, Seagen and Merck Announce Results of Clinical Trial Investigating Padcev With Keytruda and Padcev as Monotherapy in First-Line Advanced Urothelial Cancer
- Ocuphire Pharma Receives PDUFA Fee Waiver for Nyxol New Drug Application from FDA
September 13, 2022
- Phase 2a Human Viral Challenge Trial Announced to Evaluate CD388 for Universal Prevention of Influenza
- Novel Imaging Approach Reveals Important Details About Rare Eye Disease Choroideremia
September 14, 2022
- Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
- Sunstone Therapies Collaborates with MAPS to Conduct Clinical Trial of MDMA-Assisted Therapy for PTSD
September 15, 2022
- Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents
- Regeneron and Alnylam Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers
- Lipocine Announces Favorable Regulatory Pathway on Oral LPCN 1154 for Post-Partum Depression (PPD)
September 16, 2022
- WHO Expands Recommendation for Veklury® (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline
- DxTerity Receives New York Authorization for Type 1 Interferon Gene Signature Testing for Systemic Lupus Erythematosus Patients
- Intellia and Regeneron Announce Initial Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis
September 19, 2022
- Antengene Announces ATG-101 Granted Orphan Drug Designation by the U.S. FDA
- Biogen and Sage Therapeutics Present New Analyses at Psych Congress Further Evaluating the Efficacy and Safety of Zuranolone
- Publication of Adlarity Clinical Trial Data: Drug Exposure Equivalent to Oral Donepezil With Favorable GI Side Effect Profile
September 20, 2022
- AVROBIO Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration (FDA) for First Gene Therapy in Development for Cystinosis
- Xpira Pharmaceuticals Inc. Receives FDA Approval For Psilocybin Trial IND Application
- Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection
- Heart Medication Shows Potential as Treatment for Alcohol Use Disorder
September 21, 2022
- NIH-Funded Study Shows Sound Sleep Supports Immune Function
- The New England Journal of Medicine Publishes Pivotal Tofersen Data that Show Benefits in Rare, Genetic Form of ALS
- Open Label Safety Study Shows Improved Sleep for Children With ADHD After One Month of Azstarys
- Two Popular Diabetes Drugs Outperformed Others in Large Clinical Trial
September 22, 2022
- People Science and Sen-Jam Pharmaceutical partner to develop people-forward tools to study inflammation, pain, and opioid withdrawal symptoms in the real world
- Ferring Receives Positive Vote from U.S. FDA Advisory Committee for RBX2660
- A Healthy Lifestyle May Help Former Smokers Lower Their Risk of Death From All Causes
September 23, 2022
September 26, 2022
- Pulmatrix Announces Patient Dosing Completed for its Novel Inhaled Therapy PUR3100 for Acute Migraine
- Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age
- Atea Pharmaceuticals Announces U.S. FDA Fast Track Designation Granted to AT-752 for Treatment of Dengue
- Prenatal Steroid Treatment May Improve Survival, Reduce Complications for Extremely Preterm Infants
September 27, 2022
- Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint, Showing Highly Statistically Significant Reduction Of Clinical Decline In Large Global Clinical Study Of 1,795 Participants With Early Alzheimer’s Disease
- First approval of TAAV synthetic DNA material for use in clinical trial
- Study Confirms Link Between COVID-19 Vaccination and Temporary Increase in Menstrual Cycle Length
- NIH Initiative to Systematically Investigate and Establish Function of Every Human Gene
September 28, 2022
- Bionic Pancreas Improves Type 1 Diabetes Management Compared to Standard Insulin Delivery Methods
- Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib
- Mallinckrodt Announces Submission of 510(k) to the U.S. FDA for Inhaled Nitric Oxide Delivery System
September 29, 2022
September 30, 2022
Clinical trial results archive
- 2024
- January, February, March, April, May
- 2023
- January, February, March, April, May, June, July, August, September, October, November, December
- 2022
- January, February, March, April, May, June, July, August, September, October, November, December
- 2021
- January, February, March, April, May, June, July, August, September, October, November, December
- 2020
- January, February, March, April, May, June, July, August, September, October, November, December
- 2019
- January, February, March, April, May, June, July, August, September, October, November, December
- 2018
- January, February, March, April, May, June, July, August, September, October, November, December
- 2017
- May, June, July, August, September, October, November, December
- 2016
- October
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.